Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial

MLA

N. Dimier, et al. Vismodegib in Patients with Advanced Basal Cell Carcinoma: Primary Analysis of STEVIE, an International, Open-Label Trial. Jan. 2017. EBSCOhost, https://doi.org/10.1016/j.ejca.2017.08.022⟩.

APA

N. Dimier, Reinhard Dummer, C. Dutriaux, Lisa Licitra, B. Dréno, Nicole Basset-Seguin, Axel Hauschild, A. Fittipaldo, J.-J. Grob, Rainer Kunstfeld, Luc Thomas, Laurent Mortier, Bernard Guillot, I. Xynos, Johan Hansson, Nicolas Meyer, Kate Fife, A. Raimundo, Emi Dika, … P.A. Ascierto. (2017). Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial. https://doi.org/10.1016/j.ejca.2017.08.022⟩

Chicago

N. Dimier, Reinhard Dummer, C. Dutriaux, Lisa Licitra, B. Dréno, Nicole Basset-Seguin, Axel Hauschild, et al. 2017. “Vismodegib in Patients with Advanced Basal Cell Carcinoma: Primary Analysis of STEVIE, an International, Open-Label Trial,” January. doi:10.1016/j.ejca.2017.08.022⟩.